Patent directory · USPTO A61K / A61P
Patents matching “REGENERON PHARMACEUTICALS, INC.”
837 pharma patents match "REGENERON PHARMACEUTICALS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 837 pharmaceutical patents matching "REGENERON PHARMACEUTICALS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 10316105
Anti-TIE2 antibodies and uses thereof
granted -
US 10306874
Non-human animals having a humanized lymphocyte-activation gene 3
granted -
US 10285388
Non-human animals having a disruption in a C9ORF72 locus
granted -
US 10278374
Genetically modified mice and engraftment
granted -
US 10266588
Method of treating osteoarthritis with an antibody to NGF
granted -
US 10266582
GPR156 variants and uses thereof
granted -
US 10259870
Anti-ANGPTL8 antibodies and uses thereof
granted -
US 10261094
Competitive ligand binding assay for detecting neutralizing antibodies
granted -
US 10253102
Antigen-binding proteins that activate the leptin receptor
granted -
US 10251938
Angiopoietin-based interventions for treating cerebral malaria
granted -
US 10246509
Restricted immunoglobulin heavy chain mice
granted -
US 10233250
Human antibodies to the glucagon receptor and methods of use thereof for lowering blood glucose or ketone levels
granted -
US 10212923
Humanized dipeptidyl-peptidase IV (DPP4) animals
granted -
US 10206379
Non-human animals having a humanized signal-regulatory protein gene
granted -
US 10196613
Stem cells for modeling type 2 diabetes
granted -
US 10189901
Methods for improving cardiac function by administering an antibody that activates APLNR
granted -
US 10179819
Anti-PSMA antibodies, bispecific antigen-binding molecules that bind PSMA and CD3, and uses thereof
granted -
US 10162933
High resolution allele identification
granted -
US 10155811
APLNR modulators and uses thereof
granted -
US 10137193
Methods for treating or preventing asthma by administering an IL-4R antagonist
granted -
US 10130681
Use of a VEGF antagonist to treat angiogenic eye disorders
granted -
US 10123518
Genetically modified non-human animals and methods of use thereof
granted -
US 10125188
Human antibodies to respiratory syncytial virus F protein and methods of use thereof
granted -
US 10111953
Methods for reducing remnant cholesterol and other lipoprotein fractions by administering an inhibitor of proprotein convertase subtilisin kexin-9 (PCSK9)
granted